The Official Journal of the Turkish Society Of Clinical Microbiology and Infectious Diseases (KLİMİK)

Infectious Diseases

Filter Newest Oldest Showing 21-27 of 27 results
Case Report / VOLUME 5, ISSUE 4, DECEMBER 2023

Clinical Entity Mimicking Infectious Cellulitis: Eosinophilic Cellulitis (Wells’ Syndrome)

Mustafa Deniz and others

Eosinophilic cellulitis (EC) is a rare inflammatory skin condition with fewer than 200 documented cases in the medical literature. There are only a limited number of case reports available from our country. The prevalence and incidence of EC are unknown. The disease is characterized by pruritic, non-purulent, erythematous plaques (...) Read More

Original Article / VOLUME 5, ISSUE 4, DECEMBER 2023

Brucellar Epididymo-Orchitis in a Brucellosis Hyperendemic Region in Türkiye

Hatun Öztürk-Çerik and others

Brucellosis is a widespread zoonosis transmitted to humans, mainly through direct or indirect contact with infected animals. The main endemic areas are the Mediterranean region, Middle East, Central Asia, China, India, sub-Saharan Africa, and Central and South America. Brucellosis is a systemic infection with a broad clinical spectrum (...) Read More

Review Article / VOLUME 5, ISSUE 4, DECEMBER 2023

Is There a Role for Dark Field Microscopy in the Diagnosis of Lyme Disease?
A Narrative Review

Uğur Önal and others

Lyme disease, also known as Lyme borreliosis, is the most common vector-borne disease in Europe and North America, caused by the spirochete Borrelia species, which can be transmitted through the bite of an infected black-legged tick. The Centers for Disease Control and Prevention (CDC) data on Lyme disease in the United States showed (...) Read More

Correspondence / VOLUME 6, ISSUE 2, JUNE 2024

ChatGPT as a Novel Consultant in Infectious Diseases and Clinical Microbiology: Correspondence

Hinpetch Daungsupawong and Viroj Wiwanitkit

Tunçer et al. brought us interesting observations from the study “How Reliable is ChatGPT as a Novel Consultant in Infectious Diseases and Clinical Microbiology?”. In conclusion, 200 questions about infectious diseases from different platforms were used in the study, along with recommendations from reliable sources. The replies were predicated on (...) Read More

Original Article / VOLUME 6, ISSUE 2, JUNE 2024

The Impact of Reporting the Same-Day Identification and Antibiotic Susceptibility Test Results on the Treatment of Bloodstream Infections

Mervenur Demir and others

The global increase in the rate of multi-drug resistant (MDR) bacterial infections in recent years is an important public health problem that limits the therapeutic options. The issue becomes particularly critical in cases of bloodstream infections (BSI) in which delay is associated with high mortality rates. Bacteria grown in blood cultures (BC) must be subcultured on the solid media (...) Read More

Original Article / VOLUME 6, ISSUE 2, JUNE 2024

COVID-19 Vaccines and COVID-19 in People Living with HIV

Muhammed Fatih Karaşın and others

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a strain of the coronavirus that causes COVID-19, spread rapidly around the world and was defined as a pandemic on March 12, 2020, by the World Health Organization. As of June 2023, more than 767 million cases were confirmed globally, along with 6.9 million deaths. Read More

Review Article / VOLUME 6, ISSUE 2, JUNE 2024

Discontinuation of Nucleos(t)ide Analogues in HBeAg Negative Chronic Hepatitis B Patients: Risks and Benefits

Pınar Korkmaz and Neşe Demirtürk

Chronic hepatitis B (CHB) remains a major threat to global public health, affecting 296 million people worldwide. CHB increases the risk of cirrhosis, liver failure and hepatocellular carcinoma, causing liver-related morbidity and mortality. All these risks can be prevented with antiviral treatment. Although there is no curative treatment for CHB today the virus can be effectively controlled with existing (...) Read More